Caution over use of catheter ablation for atrial fibrillation

BMJ (Online)

Volumn 347, Issue 7924, 2013, Pages

  Van Brabandt, Hans ^a,b   Neyt, Mattias ^a   Devos, Carl ^a  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^b Belgian Center for Evidence Based Medicine   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FLECAINIDE;

ARTERY EMBOLISM; ARTICLE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; DEVICE SAFETY; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; ESOPHAGUS FISTULA; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; MEDICAL DEVICE REGULATION; OBSERVATIONAL STUDY; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT SELECTION; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; SINUS RHYTHM; THYROID DISEASE; UNITED KINGDOM;

ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84884566068     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f5277     Document Type: Article

References (38)

1. Kojodjojo P, Davies DW. Atrial fibrillation ablation: contemporary practice and future potential. Heart 2011;97:610-1.
2. Van Brabandt H, Neyt M, Devos C. Catheter ablation of atrial fibrillation. Health technology assessment. Belgian Health Care Knowledge Centre, 2012.
3. Van Brabandt H, Neyt M, Devos C. Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data. Europace 2013;15:663-8.
4. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation. Europace 2010;12:1360-420.
5. Atrial Fibrillation Association. The AF report. Preventing a stroke crisis. Atrial Fibrillation Association, AntiCoagulation Europe, 2011.
6. De Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 2005;165:258-62. (Pubitemid 40216276)
7. Testa L, Biondi-Zoccai GG, Dello Russo A, Bellocci F, Andreotti F, Crea F. Rate-control vs rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J 2005;26:2000-6. (Pubitemid 41439642)
8. Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2012;5:CD005049.
9. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66. (Pubitemid 28402090)
10. Potpara TS, Lip GY. Lone atrial fibrillation: where are we now? Hosp Pract 1995-2011;39:17-31.
11. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-8.
12. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007;115:3050-6. (Pubitemid 46956493)
13. Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 2009;20:22-8.
14. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008;118:2498-505.
15. Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C, Pooranawattanakul S, Punlee K, et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai 2003;86(suppl 1):S8-16.
16. MacDonald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart 2011;97:740-7.
17. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi Jr F, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006;354:934-41.
18. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol 2006;48:2340-7. (Pubitemid 44856763)
19. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 2006;27:216-21. (Pubitemid 43069040)
20. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-40. (Pubitemid 40744248)
21. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010;303:333-40.
22. Pappone C, Vicedomini G, Augello G, Manguso F, Saviano M, Baldi M, et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ Arrhythm Electrophysiol 2011;4:808-14.
23. Nielsen JC, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012;367:1587-95.
24. Morillo C, Verma A, Kuck KH. Radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: (RAAFT 2): a randomized trial. Abstract LB02-1. Heart Rhythm Society 2012 Scientific Sessions, Boston, MA, 9-12 May 2012.
25. Van Brabandt H, Neyt M, Devos C. Questionable levels of evidence in new atrial fibrillation guidelines? Europace 2013;15:461.
26. Kung J, Miller RR, Mackowiak PA. Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress. Arch Intern Med 2012:172:1628-33.
27. Shaneyfelt T. In guidelines we cannot trust: comment on "failure of clinical practice guidelines to meet Institute of Medicine standards." Arch Intern Med 2012;172:1633-4.
28. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
29. Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Williams-Andrews M, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm 2009;6:1403-12.
30. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, et al. Long-term clinical results of two different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008;1:269-75.
31. Hunter RJ, Berriman TJ, Diab I, Baker V, Finlay M, Richmond L, et al. Long-term efficacy of catheter ablation for atrial fibrillation: impact of additional targeting of fractionated electrograms. Heart 2010;96:1372-8.
32. Katritsis D, Wood MA, Giazitzoglou E, Shepard RK, Kourlaba G, Ellenbogen KA. Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation. Europace 2008;10:419-24. (Pubitemid 351767665)
33. Medi C, Sparks PB, Morton JB, Kistler PM, Halloran K, Rosso R, et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol 2011;22:137-41.
34. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010;122:2368-77.
35. Sorgente A, Tung P, Wylie J, Josephson ME. Six year follow-up after catheter ablation of atrial fibrillation: a palliation more than a true cure. Am J Cardiol 2012;109:1179-86.
36. Vinck I, Hulstaert F, Van Brabandt H, Neyt M, Stordeur S. Market introduction of innovative high risk medical devices: towards a recast of the directive concerning medical devices. Eur J Health Law 2011;18:477-89.
37. Neven K, Schmidt B, Metzner A, Otomo K, Nuyens D, De Potter T, et al. Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound. Circ Arrhythm Electrophysiol 2010;3:260-5.
38. Koch L, Haeusler KG, Herm J, Safak E, Fischer R, Malzahn U, et al. Mesh ablator vs cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: results of the MACPAF study. Europace 2012;14:1441-9.